528 related articles for article (PubMed ID: 24814494)
1. Peripartum cardiomyopathy: predictors of recovery and current state of implantable cardioverter-defibrillator use.
Pillarisetti J; Kondur A; Alani A; Reddy M; Reddy M; Vacek J; Weiner CP; Ellerbeck E; Schreiber T; Lakkireddy D
J Am Coll Cardiol; 2014 Jul; 63(25 Pt A):2831-9. PubMed ID: 24814494
[TBL] [Abstract][Full Text] [Related]
2. Primary prevention with a defibrillator: are therapies always really optimized before implantation?
Foucault A; Amelot M; Gomes S; Champ-Rigot L; Saloux E; Pellissier A; Labombarda F; Scanu P; Milliez P
Europace; 2012 Nov; 14(11):1572-7. PubMed ID: 22696518
[TBL] [Abstract][Full Text] [Related]
3. Factors predisposing to ventricular tachyarrhythmia leading to appropriate ICD intervention in patients with coronary artery disease or non-ischaemic dilated cardiomyopathy.
Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
Kardiol Pol; 2012; 70(12):1264-75. PubMed ID: 23264245
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of implantable defibrillators in octogenarians and nonagenarians for primary prevention of sudden cardiac death.
Mezu U; Adelstein E; Jain S; Saba S
Am J Cardiol; 2011 Sep; 108(5):718-22. PubMed ID: 21640321
[TBL] [Abstract][Full Text] [Related]
5. Left ventricular ejection fraction and absence of ACE inhibitor/angiotensin II receptor blocker predicts appropriate defibrillator therapy in the primary prevention population.
Obeyesekere MN; Chan W; Stub D; Prabhu S; Teo EP; Toogood G; Mariani J; Broughton A; Kistler PM
Pacing Clin Electrophysiol; 2010 Jun; 33(6):696-704. PubMed ID: 20059719
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the clinical relevance of baseline left ventricular ejection fraction as a predictor of recovery or persistence of severe dysfunction in women in the United States with peripartum cardiomyopathy.
Goland S; Bitar F; Modi K; Safirstein J; Ro A; Mirocha J; Khatri N; Elkayam U
J Card Fail; 2011 May; 17(5):426-30. PubMed ID: 21549301
[TBL] [Abstract][Full Text] [Related]
7. Risk for life-threatening arrhythmia in newly diagnosed peripartum cardiomyopathy with low ejection fraction: a German multi-centre analysis.
Duncker D; Westenfeld R; Konrad T; Pfeffer T; Correia de Freitas CA; Pfister R; Thomas D; Fürnkranz A; Andrié RP; Napp A; Schmitt J; Karolyi L; Wakili R; Hilfiker-Kleiner D; Bauersachs J; Veltmann C
Clin Res Cardiol; 2017 Aug; 106(8):582-589. PubMed ID: 28275862
[TBL] [Abstract][Full Text] [Related]
8. Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability.
Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
Kardiol Pol; 2012; 70(11):1099-110. PubMed ID: 23180517
[TBL] [Abstract][Full Text] [Related]
9. Early mortality in prophylactic implantable cardioverter-defibrillator recipients: development and validation of a clinical risk score.
Kraaier K; Scholten MF; Tijssen JG; Theuns DA; Jordaens LJ; Wilde AA; van Dessel PF
Europace; 2014 Jan; 16(1):40-6. PubMed ID: 23918791
[TBL] [Abstract][Full Text] [Related]
10. Risk for ventricular fibrillation in peripartum cardiomyopathy with severely reduced left ventricular function-value of the wearable cardioverter/defibrillator.
Duncker D; Haghikia A; König T; Hohmann S; Gutleben KJ; Westenfeld R; Oswald H; Klein H; Bauersachs J; Hilfiker-Kleiner D; Veltmann C
Eur J Heart Fail; 2014 Dec; 16(12):1331-6. PubMed ID: 25371320
[TBL] [Abstract][Full Text] [Related]
11. Long-term follow-up of implantable cardioverter-defibrillator for secondary prevention in chagas' heart disease.
Martinelli M; de Siqueira SF; Sternick EB; Rassi A; Costa R; Ramires JA; Kalil Filho R
Am J Cardiol; 2012 Oct; 110(7):1040-5. PubMed ID: 22727179
[TBL] [Abstract][Full Text] [Related]
12. Clinical Characteristics and Long-term Predictors of Persistent Left Ventricular Systolic Dysfunction in Peripartum Cardiomyopathy.
Li W; Li H; Long Y
Can J Cardiol; 2016 Mar; 32(3):362-8. PubMed ID: 26586094
[TBL] [Abstract][Full Text] [Related]
13. Right Ventricular Function in Peripartum Cardiomyopathy at Presentation Is Associated With Subsequent Left Ventricular Recovery and Clinical Outcomes.
Blauwet LA; Delgado-Montero A; Ryo K; Marek JJ; Alharethi R; Mather PJ; Modi K; Sheppard R; Thohan V; Pisarcik J; McNamara DM; Gorcsan J;
Circ Heart Fail; 2016 May; 9(5):. PubMed ID: 27166247
[TBL] [Abstract][Full Text] [Related]
14. Implantable cardioverter defibrillator for primary prevention in patients with severe ventricular dysfunction awaiting heart transplantation.
Cantero-Pérez EM; Sobrino-Márquez JM; Grande-Trillo A; Lage-Gallé E; Rangel-Sousa D; Esteve-Ruiz IM; Martínez-Martínez A
Transplant Proc; 2013; 45(10):3659-61. PubMed ID: 24314988
[TBL] [Abstract][Full Text] [Related]
15. Implantable cardioverter defibrillator therapy activation for high risk patients with relatively well preserved left ventricular ejection fraction. Does it really work?
Gatzoulis KA; Tsiachris D; Dilaveris P; Archontakis S; Arsenos P; Vouliotis A; Sideris S; Trantalis G; Kartsagoulis E; Kallikazaros I; Stefanadis C
Int J Cardiol; 2013 Aug; 167(4):1360-5. PubMed ID: 22534047
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of implantable cardiac defibrillators for treatment of ventricular arrhythmias in patients with cardiac sarcoidosis.
Kron J; Sauer W; Schuller J; Bogun F; Crawford T; Sarsam S; Rosenfeld L; Mitiku TY; Cooper JM; Mehta D; Greenspon AJ; Ortman M; Delurgio DB; Valadri R; Narasimhan C; Swapna N; Singh JP; Danik S; Markowitz SM; Almquist AK; Krahn AD; Wolfe LG; Feinstein S; Ellenbogen KA
Europace; 2013 Mar; 15(3):347-54. PubMed ID: 23002195
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic implantable cardioverter defibrillator therapy in dilated cardiomyopathy: impact of left ventricular function.
Schaer BA; Ammann P; Sticherling C; Zellweger MJ; Cron TA; Osswald S
Int J Cardiol; 2006 Mar; 108(1):26-30. PubMed ID: 16516695
[TBL] [Abstract][Full Text] [Related]
18. Left ventricular function improvement after prophylactic implantable cardioverter-defibrillator implantation in patients with non-ischaemic dilated cardiomyopathy.
Grimm W; Timmesfeld N; Efimova E
Europace; 2013 Nov; 15(11):1594-600. PubMed ID: 23639855
[TBL] [Abstract][Full Text] [Related]
19. Clinical profile and predictors of complications in peripartum cardiomyopathy.
Goland S; Modi K; Bitar F; Janmohamed M; Mirocha JM; Czer LS; Illum S; Hatamizadeh P; Elkayam U
J Card Fail; 2009 Oct; 15(8):645-50. PubMed ID: 19786252
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcomes after primary prevention defibrillator implantation are better predicted when the left ventricular ejection fraction is assessed by cardiovascular magnetic resonance.
Champ-Rigot L; Gay P; Seita F; Benouda L; Morello R; Pellissier A; Alexandre J; Saloux E; Milliez P
J Cardiovasc Magn Reson; 2020 Jun; 22(1):48. PubMed ID: 32580786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
